Western Blot analysis of cell lysates prepared from Immunohistochemical staining of formalin fixed and Immunohistochemical staining of Giant Cell Bone Image courtesy of Adrienne Flanagan, Department Immunohistochemical staining of Giant Cell Bone Image courtesy of Adrienne Flanagan, Department
Product Details
Product Name Anti-Histone H3.3 G34W Rabbit Monoclonal Antibody [RM263]
Product Description Rabbit monoclonal to Histone H3.3 G34W; Histone H3.3 G34W Mutant
Catalog No. 31-1145-00
Clone Name RM263
Product Data Sheet Anti-Histone H3.3 G34W Mutant Rabbit Monoclonal Antibody Data Sheet RM263
Specificity RM263 reacts to the Histone H3.3 G34W mutant. No cross reactivity with wild type Histone H3.3 .
Immunogen A peptide corresponding to Histone H3.3 G34W mutant
Application Western Blot
ELISA
Immunohistochemistry
Immunocytochemistry
Chromatin IP
Species Reactivity All
Conjugate None
Intended Use Research Use Only
.
Properties
Form Liquid
Storage Instructions Store at -20.0°C
Stability Stable for 1 Year at -20.0°C from date of receipt
Storage Buffer 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide
Volume/Size 50 ug
Concentration 1.0 mg/mL
Purity Protein A affinity purified from an animal origin–free culture supernatant
Clone Type Monoclonal
Isotype Rabbit IgG
Usage Western Blot: 0.5 ug/mL – 2 ug/mL;
ELISA: 0.5 ug/mL - 2 ug/mL;
Immunohistochemistry (IHC): 0.5 – 5 ug/mL;
Immunocytochemistry (ICC): 0.5 – 5 ug/mL.
References for Histone H3.3 G34W Mutant antibody [RM263] Lübbehüsen C et al. Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway. Sci Rep. (2019), 10.1038/s41598-019-42611-1. IHC-P, WB; Human. Read more (PubMed: 31015476)
Fellenberg J et al. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells. Cancer Lett. (2019), 10.1016/j.canlet.2019.02.001. IHC-P; Human. Read more (PubMed: 30742944)
Giesche, J. P et al. H3F3A mutated multicentric giant cell tumor of bone : A very rare primary bone disease. Pathologe. Springer Nature. (2018) 10.1007/s00292-018-0460-8. IHC-P; Human. Read more (PubMed: 30046846)
Lüke J. et al. New aspects on giant cell tumor of bone. Pathologe. Springer Nature. (2018) 10.1007/s00292-017-0391-9, IHC-P; Human. Read more (PubMed: 29110035)
Rehkamper J et al. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy. Oncotarget. (2018), 10.18632/oncotarget.25725. IHC-P; Human. Read more (PubMed: PMC6059026)
Tsukamoto Y et al. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation. Pathol Res Pract. (2018) 10.1016/j.prp.2018.06.015. IHC-P; Human. Read more (PubMed: 29970305)
Patel V et al. Evaluation of H3.3 G34W expression in denosumabtreated giant cell tumor of bone and histologic mimics. Mod Pathol. (2018), USCAP 2018 Abstracts-Bone & Soft Tissue Pathology (45-120). IHC-P; Human. Read more (USCAP 2018 Abstracts: 101: PubMed: 29551782)
Schaefer IM et al. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy. Cancer Cytopathol. (2018) 10.1002/cncy.22000. IHC-P; Human. Read more (PubMed: 29757500)
Scotto di Carlo F et al. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location. BMC Cancer (2018) 10.1186/s12885-018-4291-z. IHC-P; Human, IF-P; Human Read more (PubMed: 29609578)
Yamamoto H et al. Diagnostic utility of histone H3.3G34 W, G34R, and G34 V mutant-specific antibodies for giant cell tumors of bone. Human Pathology (2017) 10.1016/j.humpath.2017.11.020. IHC; Human. Read more (PubMed: 29241742)
Kato I et al. Giant Cell Tumours of Bone Treated with Denosumab: Histologic, Immunohistochemical, and H3F3A Mutation Analyses. Histopathology (2017) 10.1111/his.13448. IHC-P; Human. IF; Human. Read more (PubMed: 29206281)
Luke J et al. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant. Histopathology (2017) 10.1111/his.13190. IHC-P; Human. Read more (PubMed: 28211081)
Amary F et al. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone. AM J Surg Pathol. (2017) 10.1097/PAS.0000000000000859. IHC-P; Human. Read more (PubMed: 28505000)
.
Product Images
Related Products
Home/Primary Antibodies/Rabbit Monoclonal/Epigenetics/Histone Mutations
Anti-Histone H3.3 G34W Rabbit Monoclonal Antibody, Clone RM263; Histone H3.3 G34W Mutant (50ug)
$399.00
Rabbit monoclonal to Histone H3.3 G34W; Histone H3.3 G34W Mutant
References
Lübbehüsen C et al. Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway. Sci Rep. (2019), 10.1038/s41598-019-42611-1. IHC-P, WB; Human. Read more (PubMed: 31015476)
Fellenberg J et al. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells. Cancer Lett. (2019), 10.1016/j.canlet.2019.02.001. IHC-P; Human. Read more (PubMed: 30742944)
Giesche, J. P et al. H3F3A mutated multicentric giant cell tumor of bone : A very rare primary bone disease. Pathologe. Springer Nature. (2018) 10.1007/s00292-018-0460-8. IHC-P; Human. Read more (PubMed: 30046846)
Lüke J. et al. New aspects on giant cell tumor of bone. Pathologe. Springer Nature. (2018) 10.1007/s00292-017-0391-9, IHC-P; Human. Read more (PubMed: 29110035)
Rehkamper J et al. Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy. Oncotarget. (2018), 10.18632/oncotarget.25725. IHC-P; Human. Read more (PubMed: PMC6059026)
Tsukamoto Y et al. An extremely rare case of primary malignancy in giant cell tumor of bone, arising in the right femur and harboring H3F3A mutation. Pathol Res Pract. (2018) 10.1016/j.prp.2018.06.015. IHC-P; Human. Read more (PubMed: 29970305)
Patel V et al. Evaluation of H3.3 G34W expression in denosumabtreated giant cell tumor of bone and histologic mimics. Mod Pathol. (2018), USCAP 2018 Abstracts-Bone & Soft Tissue Pathology (45-120). IHC-P; Human. Read more (USCAP 2018 Abstracts: 101: PubMed: 29551782)
Schaefer IM et al. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy. Cancer Cytopathol. (2018) 10.1002/cncy.22000. IHC-P; Human. Read more (PubMed: 29757500)
Scotto di Carlo F et al. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location. BMC Cancer (2018) 10.1186/s12885-018-4291-z. IHC-P; Human, IF-P; Human. Read more (PubMed: 29609578)
Yamamoto H et al. Diagnostic utility of histone H3.3G34 W, G34R, and G34 V mutant-specific antibodies for giant cell tumors of bone. Human Pathology (2017) 10.1016/j.humpath.2017.11.020. IHC; Human. Read more (PubMed: 29241742)
Kato I et al. Giant Cell Tumours of Bone Treated with Denosumab: Histologic, Immunohistochemical, and H3F3A Mutation Analyses. Histopathology (2017) 10.1111/his.13448. IHC-P; Human. IF; Human. Read more (PubMed: 29206281)
Luke J et al. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant. Histopathology (2017) 10.1111/his.13190. IHC-P; Human. Read more (PubMed: 28211081)
Amary F et al. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone. AM J Surg Pathol. (2017) 10.1097/PAS.0000000000000859. IHC-P; Human. Read more (PubMed: 28505000)